REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Baird Financial Group, Inc. 60,646$1,534,9500.00%
Nuveen Asset Management, LLC 402,394$10,184,5920.00%
CarsonAllaria Wealth Management, Ltd. 195$4,9350.00%
TEACHER RETIREMENT SYSTEM OF TEXAS 22,744$5760.00%
BALDWIN BROTHERS LLC/MA 2,000$50,6200.00%
MARSHALL WACE, LLP 90,528$2,291,2640.00%
MILLENNIUM MANAGEMENT LLC 345,458$8,743,5420.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 101,534$2,569,8260.00%
NORTHERN TRUST CORP 829,774$21,001,5800.00%
PFS INVESTMENTS INC. 10,799$2730.00%
CREDIT SUISSE AG/ 142,188$3,598,7780.00%
FMR LLC 1,955,915$49,504,2090.00%
DnB Asset Management AS 21,775$551,1250.00%
Tower Research Capital LLC (TRC) 3,273$82,8400.00%
Elequin Capital, LP 264$6,6820.00%
VIRGINIA RETIREMENT SYSTEMS ET AL 13,700$346,7470.00%
VANGUARD GROUP INC 4,652,776$117,761,7610.00%
Swiss National Bank 182,550$4,620,3410.00%
Capital Advisors, Ltd. LLC 760$190.00%
RHUMBLINE ADVISERS 116,026$2,936,6180.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.